Infectious Diseases News and Research

RSS
Antiretroviral resistance testing in HIV infected patients improves health and saves costs

Antiretroviral resistance testing in HIV infected patients improves health and saves costs

AstraZeneca makes $100 million investment in Boston

AstraZeneca makes $100 million investment in Boston

Sequella receives FDA fast track status for pulmonary tuberculosis drug

Sequella receives FDA fast track status for pulmonary tuberculosis drug

More aid required for chronic conditions in developed world

More aid required for chronic conditions in developed world

Race to accelerate tuberculosis drug development

Race to accelerate tuberculosis drug development

In Vitro diagnostic market in Europe

In Vitro diagnostic market in Europe

Emory University announces new health institute

Emory University announces new health institute

MedImmune statement on MedImmune vs. Genentech Supreme Court decision

MedImmune statement on MedImmune vs. Genentech Supreme Court decision

DNA vaccine for H5N1 avian influenza enters human trial

DNA vaccine for H5N1 avian influenza enters human trial

U.S. residents slightly healthier than in 2005

U.S. residents slightly healthier than in 2005

An effective malaria vaccine by 2025

An effective malaria vaccine by 2025

New approaches to expanding HIV testing

New approaches to expanding HIV testing

Interruptions in antiretroviral treatment increases risk of developing AIDS-related diseases

Interruptions in antiretroviral treatment increases risk of developing AIDS-related diseases

In 25 years AIDS will be the number one killer disease

In 25 years AIDS will be the number one killer disease

MChip to detect H5N1

MChip to detect H5N1

Phase I clinical trial of experimental gene therapy to treat HIV shows encouraging results

Phase I clinical trial of experimental gene therapy to treat HIV shows encouraging results

Arthritis drugs not as risky as first thought

Arthritis drugs not as risky as first thought

The lifetime cost of current HIV care in the United States

The lifetime cost of current HIV care in the United States

Weill Cornell findings could foil two potential bioterror agents - viral peptide prevents deadly Hendra, Nipah viruses from infecting cells

Weill Cornell findings could foil two potential bioterror agents - viral peptide prevents deadly Hendra, Nipah viruses from infecting cells

Benign virus previously used as a marker in tracing human migration may be unreliable

Benign virus previously used as a marker in tracing human migration may be unreliable